We have changed our visitation policy for the safety of our patients and staff. Click here for the updated visitation policy and click here for information about COVID-19.

[LCID Study Number: 20193125]

NRG-GU006, A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer

The purpose of this study is to compare any good and bad effects of using the drug apalutamide along with usual radiation therapy to using usual radiation therapy alone.

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3421